FibroGen, Inc. (FGEN)

Exchange NASDAQ
11.62


Currency in USD (Disclaimer)
Volume:
Day's Range:

FGEN Insider Trading

Transaction Date Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price(USD) Amount(USD) SEC Filing
2022-06-22 Wettig Thane officer: Chief Commercial Officer 91,294.0 F-InKind D 655.0 11.42 7,480.10
2022-06-16 Henderson Jeffrey William director 25,684.0 A-Award A 25,684.0 9.00 231,156.00
2022-06-16 Henderson Jeffrey William director 33,577.0 A-Award A 15,777.0 0.00 0.00
2022-06-16 Ho Maykin director 25,684.0 A-Award A 25,684.0 9.00 231,156.00
2022-06-16 Ho Maykin director 31,732.0 A-Award A 15,777.0 0.00 0.00
2022-06-16 EDWARDS JEFFREY L director 25,684.0 A-Award A 25,684.0 9.00 231,156.00
2022-06-16 EDWARDS JEFFREY L director 33,577.0 A-Award A 15,777.0 0.00 0.00
2022-06-16 Cravatt Benjamin director 25,684.0 A-Award A 25,684.0 9.00 231,156.00
2022-06-16 Cravatt Benjamin director 24,391.0 A-Award A 15,777.0 0.00 0.00
2022-06-16 Brennan Aoife director 25,684.0 A-Award A 25,684.0 9.00 231,156.00
2022-06-16 Brennan Aoife director 24,391.0 A-Award A 15,777.0 0.00 0.00
2022-06-16 Lema Gerald director 25,684.0 A-Award A 25,684.0 9.00 231,156.00
2022-06-16 Lema Gerald director 20,477.0 A-Award A 15,777.0 0.00 0.00
2022-06-16 Blaug Suzanne director 25,684.0 A-Award A 25,684.0 9.00 231,156.00
2022-06-16 Blaug Suzanne director 29,825.0 A-Award A 15,777.0 0.00 0.00
2022-06-16 Schoeneck James A director 25,684.0 A-Award A 25,684.0 9.00 231,156.00
2022-06-16 Schoeneck James A director 20,477.0 A-Award A 15,777.0 0.00 0.00
2022-06-06 Chung Christine officer: SVP, China Operations 244,002.0 F-InKind D 1,850.0 9.50 17,575.00
2022-06-06 Wettig Thane officer: Chief Commercial Officer 89,961.0 F-InKind D 360.0 9.50 3,420.00
2022-06-06 Conterno Enrique A director, officer: Chief Executive Officer 301,940.0 F-InKind D 1,772.0 9.50 16,834.00
2022-06-01 Eisner Mark officer: Chief Medical Officer 149,800.0 F-InKind D 1,141.0 9.61 10,965.01
2022-04-07 Conterno Enrique A director, officer: Chief Executive Officer 303,712.0 F-InKind D 1,311.0 12.73 16,689.03
2022-03-31 Eisner Mark officer: Chief Medical Officer 150,941.0 F-InKind D 6,442.0 12.02 77,432.84
2022-03-31 Chung Christine officer: SVP, China Operations 245,852.0 F-InKind D 4,682.0 12.02 56,277.64
2022-03-22 Wettig Thane officer: Chief Commercial Officer 90,321.0 F-InKind D 655.0 13.31 8,718.05
2022-03-07 Wettig Thane officer: Chief Commercial Officer 90,976.0 F-InKind D 1,706.0 12.69 21,649.14
2022-03-07 Conterno Enrique A director, officer: Chief Executive Officer 305,023.0 F-InKind D 7,081.0 12.69 89,857.89
2022-03-07 Chung Christine officer: SVP, China Operations 250,534.0 F-InKind D 3,905.0 12.69 49,554.45
2022-03-01 Eisner Mark officer: Chief Medical Officer 157,383.0 F-InKind D 756.0 13.62 10,296.72
2022-02-14 Graham Juan officer: Chief Financial Officer 37,500.0 A-Award A 37,500.0 15.60 585,000.00
2022-02-14 Graham Juan officer: Chief Financial Officer 58,900.0 A-Award A 22,500.0 0.00 0.00
2022-02-14 Wettig Thane officer: Chief Commercial Officer 75,000.0 A-Award A 75,000.0 15.60 1,170,000.00
2022-02-14 Wettig Thane officer: Chief Commercial Officer 92,682.0 A-Award A 45,000.0 0.00 0.00
2022-02-14 Eisner Mark officer: Chief Medical Officer 100,000.0 A-Award A 100,000.0 15.60 1,560,000.00
2022-02-14 Eisner Mark officer: Chief Medical Officer 158,139.0 A-Award A 60,000.0 0.00 0.00
2022-02-14 Conterno Enrique A director, officer: Chief Executive Officer 298,000.0 A-Award A 298,000.0 15.60 4,648,800.00
2022-02-14 Conterno Enrique A director, officer: Chief Executive Officer 312,104.0 A-Award A 179,400.0 0.00 0.00
2022-02-14 Chung Christine officer: SVP, China Operations 75,000.0 A-Award A 75,000.0 15.60 1,170,000.00
2022-02-14 Chung Christine officer: SVP, China Operations 254,439.0 A-Award A 45,000.0 0.00 0.00
2022-01-06 Conterno Enrique A director, officer: Chief Executive Officer 132,704.0 F-InKind D 1,536.0 13.93 21,396.48
2022-01-03 Chung Christine officer: SVP, China Operations 209,439.0 F-InKind D 5,284.0 14.82 78,308.88
2022-01-03 Eisner Mark officer: Chief Medical Officer 98,139.0 F-InKind D 7,043.0 14.82 104,377.26
2021-12-22 Wettig Thane officer: Chief Commercial Officer 47,682.0 F-InKind D 517.0 14.97 7,739.49
2021-12-06 Chung Christine officer: SVP, China Operations 214,723.0 F-InKind D 2,668.0 14.19 37,858.92
2021-12-01 Eisner Mark officer: Chief Medical Officer 105,182.0 F-InKind D 4,338.0 12.65 54,875.70
2021-10-06 Conterno Enrique A director, officer: Chief Executive Officer 134,239.0 F-InKind D 1,859.0 10.20 18,961.80
2021-10-04 Chung Christine officer: SVP, China Operations 32,360.0 A-Award A 32,360.0 9.93 321,334.80
2021-10-04 Chung Christine officer: SVP, China Operations 217,391.0 A-Award A 54,170.0 0.00 0.00
2021-10-04 Eisner Mark officer: Chief Medical Officer 44,520.0 A-Award A 44,520.0 9.93 442,083.60
2021-10-04 Eisner Mark officer: Chief Medical Officer 109,520.0 A-Award A 74,520.0 0.00 0.00
2021-09-22 Wettig Thane officer: Chief Commercial Officer 48,196.0 F-InKind D 620.0 10.18 6,311.60
2021-09-15 KEARNS THOMAS F JR director 39,764.0 S-Sale D 13,100.0 11.58 151,707.17
2021-09-07 Chung Christine officer: SVP, China Operations 165,251.0 F-InKind D 2,030.0 12.41 25,192.30
2021-09-07 Cotroneo Pat officer: SVP, Finance and CFO 274,536.0 F-InKind D 2,141.0 12.41 26,569.81
2021-09-07 Graham Juan officer: Chief Financial Officer 196,000.0 A-Award A 196,000.0 12.41 2,432,360.00
2021-09-07 Graham Juan officer: Chief Financial Officer 36,400.0 A-Award A 35,000.0 0.00 0.00
2021-08-26 Wettig Thane officer: Chief Commercial Officer 48,816.0 P-Purchase A 3,100.0 11.53 35,743.00
2021-07-06 Conterno Enrique A director, officer: Chief Executive Officer 136,098.0 F-InKind D 1,859.0 25.06 46,586.54
2021-06-22 Wettig Thane officer: Chief Commercial Officer 45,716.0 F-InKind D 2,593.0 27.65 71,696.45
2021-06-15 Cotroneo Pat officer: SVP, Finance and CFO 276,677.0 S-Sale D 4,053.0 25.62 103,837.86
2021-06-07 Chung Christine officer: SVP, China Operations 165,251.0 F-InKind D 2,030.0 22.90 46,487.00
2021-06-07 Cotroneo Pat officer: SVP, Finance and CFO 280,730.0 F-InKind D 2,141.0 22.90 49,028.90
2021-05-26 Brennan Aoife director 7,800.0 A-Award A 7,800.0 20.86 162,708.00
2021-05-26 Brennan Aoife director 8,614.0 A-Award A 4,700.0 0.00 0.00
2021-05-26 KEARNS THOMAS F JR director 52,864.0 A-Award A 4,700.0 0.00 0.00
2021-05-26 KEARNS THOMAS F JR director 7,800.0 A-Award A 7,800.0 20.86 162,708.00
2021-05-26 Schoeneck James A director 14,100.0 A-Award A 4,700.0 0.00 0.00
2021-05-26 Schoeneck James A director 7,800.0 A-Award A 7,800.0 20.86 162,708.00
2021-05-26 RIGGS RORY B director 395,750.0 A-Award A 4,700.0 0.00 0.00
2021-05-26 RIGGS RORY B director 7,800.0 A-Award A 7,800.0 20.86 162,708.00
2021-05-26 Cravatt Benjamin director 8,614.0 A-Award A 4,700.0 0.00 0.00
2021-05-26 Cravatt Benjamin director 7,800.0 A-Award A 7,800.0 20.86 162,708.00
2021-05-26 EDWARDS JEFFREY L director 7,800.0 A-Award A 7,800.0 20.86 162,708.00
2021-05-26 Henderson Jeffrey William director 7,800.0 A-Award A 7,800.0 20.86 162,708.00
2021-05-26 Ho Maykin director 15,955.0 A-Award A 4,700.0 0.00 0.00
2021-05-26 Ho Maykin director 7,800.0 A-Award A 7,800.0 20.86 162,708.00
2021-05-26 Lema Gerald director 9,400.0 A-Award A 4,700.0 0.00 0.00
2021-05-26 Lema Gerald director 7,800.0 A-Award A 7,800.0 20.86 162,708.00
2021-05-26 Kurkijarvi Kalevi director 37,800.0 A-Award A 4,700.0 0.00 0.00
2021-05-26 Kurkijarvi Kalevi director 7,800.0 A-Award A 7,800.0 20.86 162,708.00
2021-05-26 Blaug Suzanne director 14,048.0 A-Award A 4,700.0 0.00 0.00
2021-05-26 Blaug Suzanne director 7,800.0 A-Award A 7,800.0 20.86 162,708.00
2021-05-26 EDWARDS JEFFREY L director 17,800.0 A-Award A 4,700.0 0.00 0.00
2021-05-26 Henderson Jeffrey William director 17,800.0 A-Award A 4,700.0 0.00 0.00
2021-03-11 KEARNS THOMAS F JR director 166,164.0 M-Exempt A 18,000.0 35.02 630,360.00
2021-03-11 KEARNS THOMAS F JR director 0.0 M-Exempt D 12,000.0 3.50 42,000.00
2021-03-11 KEARNS THOMAS F JR director 148,164.0 S-Sale D 18,000.0 35.02 630,360.00
2021-03-08 Chung Christine officer: SVP, China Operations 166,597.0 F-InKind D 5,679.0 33.37 189,508.23
2021-03-08 Cotroneo Pat officer: SVP, Finance and CFO 282,187.0 F-InKind D 5,657.0 33.37 188,774.09
2021-03-08 Kouchakji Elias officer: SVP, Clinical Dev, Drug Safety 147,346.0 F-InKind D 5,221.0 33.37 174,224.77
2021-02-24 Wettig Thane officer: Chief Commercial Officer 47,150.0 A-Award A 16,500.0 0.00 0.00
2021-02-24 Wettig Thane officer: Chief Commercial Officer 32,100.0 A-Award A 32,100.0 53.01 1,701,621.00
2021-02-24 Kouchakji Elias officer: SVP, Clinical Dev, Drug Safety 152,567.0 A-Award A 20,800.0 0.00 0.00
2021-02-24 Kouchakji Elias officer: SVP, Clinical Dev, Drug Safety 39,900.0 A-Award A 39,900.0 53.01 2,115,099.00
2021-02-24 Cotroneo Pat officer: SVP, Finance and CFO 287,844.0 A-Award A 21,700.0 0.00 0.00
2021-02-24 Cotroneo Pat officer: SVP, Finance and CFO 41,700.0 A-Award A 41,700.0 53.01 2,210,517.00
2021-02-24 Chung Christine officer: SVP, China Operations 172,276.0 A-Award A 21,700.0 0.00 0.00
2021-02-24 Chung Christine officer: SVP, China Operations 41,700.0 A-Award A 41,700.0 53.01 2,210,517.00
2021-02-24 Conterno Enrique A director, officer: Chief Executive Officer 137,273.0 A-Award A 82,000.0 0.00 0.00
2021-02-24 Conterno Enrique A director, officer: Chief Executive Officer 164,000.0 A-Award A 164,000.0 53.01 8,693,640.00

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.